Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity.
about
Invariant NKT cells as novel targets for immunotherapy in solid tumorsThe Role of Invariant Natural Killer T Cells in Dendritic Cell Licensing, Cross-Priming, and Memory CD8(+) T Cell GenerationUniversal immunity to influenza must outwit immune evasionVaccination in the elderlyNew ways to turn on NKT cellsNatural T Cell-mediated Protection against Seasonal and Pandemic Influenza. Results of the Flu Watch Cohort Studyα-Galactosylceramide protects swine against influenza infection when administered as a vaccine adjuvant.Role of CD8(+) T-cell immunity in influenza infection: potential use in future vaccine development.Sublingual vaccination induces mucosal and systemic adaptive immunity for protection against lung tumor challenge.Activation of the STING adaptor attenuates experimental autoimmune encephalitis.B-lymphoid cells with attributes of dendritic cells regulate T cells via indoleamine 2,3-dioxygenaseCytokine dependent and independent iNKT cell activationMemories that last forever: strategies for optimizing vaccine T-cell memory.Secretion of IFN-gamma but not IL-17 by CD1d-restricted NKT cells enhances rejection of skin grafts expressing epithelial cell-derived antigen.Alpha-galactosylceramide as a therapeutic agent for pulmonary Mycobacterium tuberculosis infection.Mycobacterium tuberculosis whole cell lysate enhances proliferation of CD8 positive lymphocytes and nitric oxide secretion in the lungs of live porcine respiratory and reproductive syndrome virus vaccinated pigsActivated iNKT cells promote memory CD8+ T cell differentiation during viral infectionNovel cancer vaccine based on genes of Salmonella pathogenicity island 2.Invariant NKT cells: regulation and function during viral infection.Effective cancer vaccine platform based on attenuated salmonella and a type III secretion systemNatural killer T cell and TLR9 agonists as mucosal adjuvants for sublingual vaccination with clade C HIV-1 envelope protein.Induction and role of indoleamine 2,3 dioxygenase in mouse models of influenza a virus infectionEnhancement of Mucosal Immunogenicity of Viral Vectored Vaccines by the NKT Cell Agonist Alpha-Galactosylceramide as Adjuvant.NKT cells inhibit antigen-specific effector CD8 T cell induction to skin viral proteins.Virus aggregating peptide enhances the cell-mediated response to influenza virus vaccineThe role of indoleamine 2, 3 dioxygenase in regulating host immunity to leishmania infectionAdjuvants in the Driver's Seat: How Magnitude, Type, Fine Specificity and Longevity of Immune Responses Are Driven by Distinct Classes of Immune PotentiatorsImpact of sugar stereochemistry on natural killer T cell stimulation by bacterial glycolipids.Altered tryptophan metabolism as a paradigm for good and bad aspects of immune privilege in chronic inflammatory diseases.Combination of the toll like receptor agonist and α-Galactosylceramide as an efficient adjuvant for cancer vaccine.Comparative analysis of routes of immunization of a live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in a heterologous virus challenge study.Dendritic cells, indoleamine 2,3 dioxygenase and acquired immune privilegeIDO activates regulatory T cells and blocks their conversion into Th17-like T cells.Altered Hepa1-6 cells by dimethyl sulfoxide (DMSO)-treatment induce anti-tumor immunity in vivoInhibition of indoleamine 2,3-dioxygenase enhances the T-cell response to influenza virus infectionIndoleamine 2,3-dioxygenase activity contributes to local immune suppression in the skin expressing human papillomavirus oncoprotein e7.The role of invariant natural killer T cells in microbial immunityTargeting the immunoregulatory indoleamine 2,3 dioxygenase pathway in immunotherapy.Innate-like recognition of microbes by invariant natural killer T cells.NKT cells: friend or foe during viral infections?
P2860
Q21284987-438325E5-1200-48C1-8AEA-701DCED06D2AQ26797344-7A03FE0C-27C8-4285-B188-C80CCB8E95E5Q26991896-0102CC0E-8B32-488A-A3BE-DB5904B8D309Q27022304-1045C0D0-4021-4EED-8B8C-DCF540C9AB6AQ27693911-E57D48C8-D36E-4DC6-A4D1-28ACDCCC5F11Q30373419-068132B6-A39D-4682-85F6-D6E59DAC67F3Q30385957-1B417E77-6AC7-4B4A-8C5F-831305C1BF4AQ30389274-FA9E590C-BBC1-4713-90AC-5C1051E36C11Q31153121-C37A4750-FE91-470E-9189-42497331FA26Q33861332-0A291397-9F19-40BD-B67A-1A575B92D7FCQ33934819-D4932EA5-550A-4283-8AE3-325D881C2934Q34039891-E1EE5EA7-2AEE-4D4D-B65A-33DEDCE947BCQ34060493-063D8761-F0B2-4DC1-91D4-C7800CD2AE8DQ34065735-AF2F99DB-D8E5-4F80-8A46-CD391C450F3BQ34172161-DE8DFD17-04BA-4D9A-9899-079EE3499D9FQ34269264-F05775FB-B1C0-4F26-BF86-7D07A42561C7Q34287659-D722DB2D-5D66-4FE1-9D05-64E40F96D25EQ34357503-3C27AFA4-A12F-48F7-89B5-8F776E4379A0Q34390484-3C0DDA83-BEA3-4761-BB2D-A3672F270746Q34438443-B7AC26A0-C02A-464E-AF39-076E651728F6Q34625185-4CC5705F-0864-4828-B7A7-C98A081C6FE5Q34778943-306D97ED-E12E-446D-9AC6-1E55CCEE452EQ34781602-9360C64E-D796-4EA2-8A9D-2C35CF090F7DQ35147733-ACCDCC32-2F8A-4529-8132-55588DADF585Q35301495-4A0E2AFD-CF58-4407-9EAE-BC969A1E5E32Q35808796-DD7422C7-8B6D-44DB-8E44-FD6CE9A7A5ADQ35826747-DD313ED9-2E1E-41F6-89AA-BBA2CF4B24C6Q35841349-19069436-788E-455B-8CCB-6C2B841CDA7DQ35952614-332CAF34-8B80-4497-AF8F-C6B3D2B59C52Q36503451-C5E47B8D-EFFC-4FA5-8A9B-FF19FC992EA2Q36700988-5437D56B-3AF7-4165-B86D-85870BFC9482Q36899012-926FD6EA-3829-4986-B291-EA42601DC01BQ36914732-0E3CE2B0-4D47-4A2D-9A7B-AF9966AE4561Q36962599-FAD7E1F3-F26C-44ED-820D-D9D1BD341A72Q37006795-3FFA4C3D-74AC-40B2-BD5E-37DB7E89BE9DQ37188781-08183B79-3C48-4309-AEFB-1D12F6FB64C5Q37292523-19E82DEC-AB24-4350-B959-10364ADBA5F8Q37352554-4FA78F88-D36D-4DC6-A583-3551135896F6Q37398859-B282CAD7-6EF3-437F-A3AB-C797A1569A15Q37615203-638B7E91-4B3F-4D14-992C-A48570B29837
P2860
Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Combined NKT cell activation a ...... ation and protective immunity.
@ast
Combined NKT cell activation a ...... ation and protective immunity.
@en
type
label
Combined NKT cell activation a ...... ation and protective immunity.
@ast
Combined NKT cell activation a ...... ation and protective immunity.
@en
prefLabel
Combined NKT cell activation a ...... ation and protective immunity.
@ast
Combined NKT cell activation a ...... ation and protective immunity.
@en
P2860
P50
P356
P1476
Combined NKT cell activation a ...... ation and protective immunity.
@en
P2093
Carole Guillonneau
François-Xavier Hubert
P2860
P304
P356
10.1073/PNAS.0813309106
P407
P50
P577
2009-02-11T00:00:00Z